Skip to main content

Table 1 Demographics and presentation comparing patients with or without a common bile duct stone image on cholangiogram

From: Management of suspected common bile duct stones on cholangiogram during same-stay cholecystectomy for acute gallstone-related disease

  

Total (N = 399)

CBD stone (N = 50)

No CBD stone (N = 349)

P value

Gender

Male, No. (%)

175 (43.9%)

16 (32%)

159 (45.6%)

.07

Female, No. (%)

224 (56.1%)

34 (68%)

190 (54.4%)

Age (mean ± SD), years

 

56 ± 19

47 ± 20

55 ± 18

.01

BMI (mean ± SD), kg/m2

 

28 ± 6

29 ± 6

28 ± 5

.58

Clinical presentation

Fever, No. (%)

42 (10.5%)

1 (2%)

41 (11.7%)

.04

RUQ pain on admission, No. (%)

355 (89%)

42 (84%)

313 (89.7%)

.23

Associated cholecystitis, No. (%)

325 (81.5%)

33 (66%)

292 (83.7%)

.003

Admission LFTs (mean ± SD)

ASAT, IU/L

 

167 ± 184

67 ± 146

.001

ALAT, IU/L

 

166 ± 197

68 ± 121

.001

PA, IU/L

 

123 ± 97

81 ± 48

.005

GGT, IU/L

 

245 ± 276

94 ± 139

.001

Total Bilirubin, μmol/L

 

26 ± 17

20 ± 12

.01

Conjugated Bilirubin, μmol/L

 

18 ± 10

9 ± 7

.002

Abnormal admission LFTs

ASAT (11–42 IU/L), No. (%)

162 (40.6%)

36 (72%)

126 (36.1%)

< .001

ALAT (9–42 IU/L), No. (%)

163 (40.9%)

34 (68%)

129 (37%)

< .001

PA (30–125 IU/L), No. (%)

75 (18.8%)

14 (28%)

61 (17.5%)

.07

GGT (9–35 IU/L), No. (%)

261 (65.4%)

43 (86%)

218 (62.5%)

.001

Total Bilirubin (7–25 μmol/L), No. (%)

97 (24.3%)

20 (40%)

77 (22.1%)

.006

Conjugated Bilirubin (2–9 μmol/L), No. (%)

319 (79.9%)

45 (90%)

274 (78.5%)

.06

  1. BMI Body Mass Index, RUQ Right Upper Quadrant, CBD Common Bile Duct, LFTs Liver Function Tests, SD Standard Deviation, ASAT Aspartate Aminotransferase, ALAT Alanine Aminotransferase, PA Alkaline Phosphatase, GGT Gamma-glutamyl Transferase